TY - JOUR
T1 - Papilledema from gain-of-function mutations in the STAT3 gene
AU - Suh, Young Woo
AU - Horton, Jonathan C.
N1 - Funding Information:
This work was supported by grants EY 029703 (J.C.H.), EY02162 (Beckman Vision Center) from the National Eye Institute and by an unrestricted grant from Research to Prevent Blindness.
Publisher Copyright:
© 2019, © 2019 Taylor & Francis Group, LLC.
PY - 2019/3/4
Y1 - 2019/3/4
N2 - Background: Signal Transducer and Activator of Transcription 3 (STAT3) gain-of-function germline mutations are associated with diverse clinical manifestations, including autoimmune cytopenia, lymphadenopathy, immunodeficiency, endocrinopathy, and enteropathy. We describe a new feature: raised intracranial pressure with papilledema. Materials and Methods: Report of two cases. Results: The first patient had a de novo heterozygous c.2144C>T (p.Pro715Leu) mutation in the STAT3 gene. At age 1 she had papilledema with marked sheathing of the proximal vessels on the optic discs. Follow-up 8 years later showed chronic papilledema, cystoid macular edema, and vision loss. The second patient had a de novo heterozygous c.2147C>T (p.Thr716Met) mutation. At age 12 he developed papilledema, which recurred despite treatment. In both patients, repeated sampling of the cerebrospinal fluid demonstrated a lymphocytic pleocytosis. Conclusions: Papilledema can occur as a manifestation of STAT3 gain-of-function mutation, sometimes accompanied by prominent vascular sheathing and cystoid macular edema. The mechanism may be chronic meningeal infiltration by white blood cells, impairing cerebrospinal fluid absorption.
AB - Background: Signal Transducer and Activator of Transcription 3 (STAT3) gain-of-function germline mutations are associated with diverse clinical manifestations, including autoimmune cytopenia, lymphadenopathy, immunodeficiency, endocrinopathy, and enteropathy. We describe a new feature: raised intracranial pressure with papilledema. Materials and Methods: Report of two cases. Results: The first patient had a de novo heterozygous c.2144C>T (p.Pro715Leu) mutation in the STAT3 gene. At age 1 she had papilledema with marked sheathing of the proximal vessels on the optic discs. Follow-up 8 years later showed chronic papilledema, cystoid macular edema, and vision loss. The second patient had a de novo heterozygous c.2147C>T (p.Thr716Met) mutation. At age 12 he developed papilledema, which recurred despite treatment. In both patients, repeated sampling of the cerebrospinal fluid demonstrated a lymphocytic pleocytosis. Conclusions: Papilledema can occur as a manifestation of STAT3 gain-of-function mutation, sometimes accompanied by prominent vascular sheathing and cystoid macular edema. The mechanism may be chronic meningeal infiltration by white blood cells, impairing cerebrospinal fluid absorption.
KW - Evans syndrome
KW - cystoid macular edema
KW - signal transducer and activator of transcription
KW - transcription factor
UR - http://www.scopus.com/inward/record.url?scp=85063900476&partnerID=8YFLogxK
U2 - 10.1080/13816810.2019.1592202
DO - 10.1080/13816810.2019.1592202
M3 - Article
C2 - 30942636
AN - SCOPUS:85063900476
SN - 1381-6810
VL - 40
SP - 165
EP - 169
JO - Ophthalmic Genetics
JF - Ophthalmic Genetics
IS - 2
ER -